Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rachel A. McGinn"'
Autor:
Sydney J. Conner, Justinne R. Guarin, Thanh T. Le, Jackson P. Fatherree, Charlotte Kelley, Samantha L. Payne, Savannah R. Parker, Hanan Bloomer, Crystal Zhang, Kenneth Salhany, Rachel A. McGinn, Emily Henrich, Anna Yui, Deepti Srinivasan, Hannah Borges, Madeleine J. Oudin
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-16 (2024)
Abstract Background Metastasis is the leading cause of death in breast cancer patients. For metastasis to occur, tumor cells must invade locally, intravasate, and colonize distant tissues and organs, all steps that require tumor cell migration. The m
Externí odkaz:
https://doaj.org/article/7a4e67d5306d4959bd38e1ceb19aa28a
Autor:
Madeleine J. Oudin, Stephen P. Naber, Rachel A. McGinn, Justinne R. Guarin, Jackson P. Fatherree
Supplementary Data from Chemotherapy-Induced Collagen IV Drives Cancer Cell Motility through Activation of Src and Focal Adhesion Kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c43e95e2e8d4395defe1610a8b1ddcc
https://doi.org/10.1158/0008-5472.22431292.v1
https://doi.org/10.1158/0008-5472.22431292.v1
Autor:
Madeleine J. Oudin, Stephen P. Naber, Rachel A. McGinn, Justinne R. Guarin, Jackson P. Fatherree
Triple-negative breast cancer (TNBC) is the most aggressive and deadly subtype of breast cancer, accounting for 30,000 cases annually in the United States. While there are several clinical trials ongoing to identify new agents to treat TNBC, the majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::698185129257b81942f7be868db357cf
https://doi.org/10.1158/0008-5472.c.6513865.v1
https://doi.org/10.1158/0008-5472.c.6513865.v1
Autor:
Jackson P. Fatherree, Justinne R. Guarin, Rachel A. McGinn, Stephen P. Naber, Madeleine J. Oudin
Publikováno v:
Cancer Research. 82:2031-2044
Triple-negative breast cancer (TNBC) is the most aggressive and deadly subtype of breast cancer, accounting for 30,000 cases annually in the United States. While there are several clinical trials ongoing to identify new agents to treat TNBC, the majo
Chemotherapy-induced collagen IV drives cancer cell invasion through activation of Src/FAK signaling
Triple-negative breast cancer (TNBC) is the most aggressive and deadly subtype of breast cancer, accounting for 30,000 cases annually in the US. While there are several clinical trials ongoing to identify new agents to treat TNBC, the majority of TNB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cf7bc9506c16f8858f7b6032f7a5bd2
https://doi.org/10.1101/2021.04.01.438074
https://doi.org/10.1101/2021.04.01.438074
Autor:
Stephen P. Naber, Rachel A. McGinn, Andrew S. Greenberg, Justinne Guarin, Andrew Wishart, Sydney J. Conner, Jackson P. Fatherree, Madeleine J. Oudin, Rebecca Crews, Yifan Peng, Martin Hunter
Publikováno v:
Science Advances
Collagen VI, an ECM protein up-regulated in triple-negative breast cancer and obese individuals, drives breast cancer metastasis.
The extracellular matrix (ECM), a major component of the tumor microenvironment, promotes local invasion to drive m
The extracellular matrix (ECM), a major component of the tumor microenvironment, promotes local invasion to drive m
Publikováno v:
Cancer Research. 81:LT001-LT001
Triple-negative breast cancer (TNBC) is the most aggressive and deadly subtype of breast cancer. TNBC is commonly treated with neoadjuvant chemotherapy followed by surgical resection; however, up to 25% will recur within five years. Cytotoxic chemoth